Founded Year
2005Stage
Unattributed VC - III | AliveTotal Raised
$53.66MLast Raised
$34.05M | 5 yrs agoAbout OxThera
OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera's intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria.
OxThera Headquarter Location
Regeringsgatan 111
Stockholm, 111 39,
Sweden
+46 8 660 02 23
Latest OxThera News
Jun 14, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Astrazeneca, Celltrion, Daiichi, Eyegate, G1, Immvira, Novan, Novavax, Oxthera, Precigen, Roche, Scholar Rock, Terns, Tyme, Vertex, Zynerba.
Expert Collections containing OxThera
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OxThera is included in 3 Expert Collections, including Pharma Startups.
Pharma Startups
6,549 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Rare Diseases
229 items
Biopharmaceuticals
13,989 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
OxThera Patents
OxThera has filed 14 patents.
The 3 most popular patent topics include:
- Kidney diseases
- Gastrointestinal tract disorders
- Oxalates
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/27/2018 | 4/27/2021 | Ion channels, Kidney diseases, Rare diseases, Gastrointestinal tract disorders, Autosomal recessive disorders | Grant | |
Application Date | 9/27/2018 | ||||
|---|---|---|---|---|---|
Grant Date | 4/27/2021 | ||||
Title | |||||
Related Topics | Ion channels, Kidney diseases, Rare diseases, Gastrointestinal tract disorders, Autosomal recessive disorders | ||||
Status | Grant |
